Pharmacy utilization and the Medicare Modernization Act. (Q36078786)

12 August 2017

1 reference

title

Pharmacy utilization and the Medicare Modernization Act. (English)

1 reference

12 August 2017

0 references

Vittorio Maio

1

1 reference

12 August 2017

Laura Pizzi

2

1 reference

12 August 2017

Adam R Roumm

3

1 reference

12 August 2017

Janice Clarke

4

1 reference

12 August 2017

Neil I Goldfarb

5

1 reference

12 August 2017

David B Nash

6

1 reference

12 August 2017

David Chess

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

83

1 reference

12 August 2017

1

1 reference

12 August 2017

101-130

1 reference

A political history of medicare and prescription drug coverage

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

How beneficiaries fare under the new Medicare drug bill.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

The effect of incentive-based formularies on prescription-drug utilization and spending

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Approaches to pharmacy benefit management and the impact of consumer cost sharing

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Effect of tiered prescription copayments on the use of preferred brand medications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Effects of restrictive formularies in the ambulatory care setting

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Managing prescription drug costs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Generic substitution: issues for problematic drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Drugs and the elderly, Part 1: The problems facing managed care

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Formulary limitations and the elderly: results from the Managed Care Outcomes Project.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Prescription cost sharing: economic and health impacts, and implications for health policy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

National health expenditures, 1988. Office of National Cost Estimates.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Clinical outcome of a mandatory formulary switch for dihydropyridine calcium channel blocker therapy at a Veteran's Administration Medical Center

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Lessons from international experience in controlling pharmaceutical expenditure. I: Influencing patients.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Financial Disparities In Prescription Drug Use Between Elderly And Nonelderly Americans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Employer drug benefit plans and spending on prescription drugs

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Adverse events associated with prescription drug cost-sharing among poor and elderly persons

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Exhaustion of drug benefits and disenrollment of medicare beneficiaries from managed care organizations.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Who bears the burden of Medicaid drug copayment policies?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Inadequate prescription-drug coverage for Medicare enrollees--a call to action

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Ability to pay and the decision to medicate

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

A critical analysis of studies of state drug reimbursement policies: research in need of discipline

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Drug formularies: myths-in-formation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Medicare beneficiaries' management of capped prescription benefits.

11 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0887-378X.2005.00337.X

Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0887-378X.2005.00337.X

Substitution of generic warfarin for Coumadin in an HMO setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0887-378X.2005.00337.X

Lipid-lowering efficacy, safety, and costs of a large-scale therapeutic statin formulary conversion program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0887-378X.2005.00337.X

Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0887-378X.2005.00337.X

Impact of health plan design and management on retirees' prescription drug use and spending, 2001.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

The challenge of expanding health benefits for the aged.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690380

A public-policy strategy for drug formularies: preparation or procrastination?

23 September 2018

1 reference

12 December 2020

Health risks, ability to pay, and the use of primary care: is the distribution of service effective and equitable?

1 reference

12 December 2020

Therapeutic substitution of cimetidine for nizatidine was not associated with an increase in healthcare utilization

1 reference

12 December 2020

Exhaustion of prescription benefits and Medicare beneficiaries' disenrollment from managed care

1 reference

12 December 2020

Medicare and prescription drugs

1 reference

12 December 2020

Growing differences between Medicare beneficiaries with and without drug coverage

1 reference

12 December 2020

Impact of a cost-sharing drug insurance plan on drug utilization among older people

1 reference

12 December 2020

Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?

1 reference

12 December 2020

The effect of a Medicaid drug copayment program on the utilization and cost of prescription services

1 reference

12 December 2020

The differential impact of copayment on drug use in a Medicaid population

1 reference

12 December 2020

Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes

1 reference

12 December 2020

HMO formularies and care costs

1 reference

12 December 2020

Drug formularies provide a path to best care

1 reference

12 December 2020

Generic substitution and optimal patient care

1 reference

12 December 2020

10.1111/J.0887-378X.2005.00337.X

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

1 reference